REGULATION OF GROWTH-HORMONE (GH), INSULIN-LIKE GROWTH-FACTOR (IGF)-I, IGF BINDING PROTEIN-1, PROTEIN-2, PROTEIN-3 AND GH BINDING-PROTEIN DURING PROGRESSION OF LIVER-CIRRHOSIS
J. Kratzsch et al., REGULATION OF GROWTH-HORMONE (GH), INSULIN-LIKE GROWTH-FACTOR (IGF)-I, IGF BINDING PROTEIN-1, PROTEIN-2, PROTEIN-3 AND GH BINDING-PROTEIN DURING PROGRESSION OF LIVER-CIRRHOSIS, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 103(5), 1995, pp. 285-291
The aim of this study was to investigate the regulation of various pro
teins of the GHIGF axis during progression of liver failure and to sea
rch for potential prognostic markers of functional hepatic reserve. Se
rum levels of growth hormone (GH) and high affinity growth hormone bin
ding protein (GHBP), insulin-like growth factor I (IGF-I) and IGF bind
ing proteins (IGFBP)-1, -2 and -3 were determined in patients with liv
er cirrhosis. A continuous decline in the concentrations of IGF-I, IGF
BP-3 and serum GH-binding activity (GHBP) was observed during progress
ion of cirrhosis and the data correlated significantly with choline es
terase, total serum protein and the Child score. In addition, GHBP sho
wed a significant correlation with the enzymatic activity of glutamate
dehydrogenase or transaminases and seems so to be influenced by the d
egree of liver cell damage. In contrast, IGFBP-1 and IGFBP-2 levels we
re significantly elevated in preterminal disease suggesting an upregul
atory mechanism is still effective in this situation. Only when liver
function had markedly deteriorated, the serum levels of these two para
meters decreased again, possibly due to an impaired synthesis. The exc
ellent correlation between the serum levels of IGF-I (r = -0.64, p < 0
.001) or IGFBP-3 (r = -0.67, p < 0.001) and the Child score index sugg
ests that they reflect the hepatic functions just as conventional indi
cators. For an appropriate interpretation of the liver function the me
asurement of the growth related peptides can be a valuable tool to est
imate pathological alteration in the functional hepatic reserve or in
the glucose homeostasis.